We are live on
!
Find out more
IV
Industry Ventures Portfolio holdings
AUM
$43.2M
1-Year Est. Return
36.57%
This Fund
S&P 500
This Quarter
Est. Return
-28.42%
1 Year Est. Return
+36.57%
3 Year Est. Return
-37.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$159M
AUM Growth
-$72M
(-31%)
Cap. Flow
+$1.45M
Cap. Flow
% of AUM
0.91%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
1
Increased
–
Reduced
2
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coupang
CPNG
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UiPath
PATH
|
+$6.48M |
| 2 |
Marqeta
MQ
|
+$5.22M |
| 3 |
Planet Labs
PL
|
+$2.17M |
| 4 |
TWAV
TaoWeave Inc
TWAV
|
+$373K |
| 5 |
Natera
NTRA
|
+$30K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 70.58% |
| 2 | Healthcare | 13.2% |
| 3 | Consumer Discretionary | 8.18% |
| 4 | Consumer Staples | 6.79% |
| 5 | Industrials | 0.77% |
Similar funds
RCM
GF
NV
EPWM
GF
SCMC
AS
BCP
Industry Ventures's Q1 2022 Portfolio in Review
As of Q1 2022, Industry Ventures held 11 positions worth $159M, down 31% from $231M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Industry Ventures's Q1 2022 filing shows 1 new, 2 reduced and 3 closed positions. Its largest new stake was Coupang: 736,057 shares worth $13M. The largest sale was UiPath, an estimated $6.48M.
By sector, the portfolio is most concentrated in Technology at 71% of assets, down from 83% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Industry Ventures's largest Q1 2022 buy was Coupang: 736,057 shares worth $13M.
- Industry Ventures's biggest Q1 2022 reduction was Marqeta, cutting an estimated $5.22M.
- Industry Ventures fully exited UiPath in Q1 2022, selling an estimated $6.48M.
- Industry Ventures's ten largest holdings make up 100% of its $159M portfolio in Q1 2022.
- Industry Ventures opened 1 new position and closed 3 in Q1 2022.
- Industry Ventures's portfolio value fell 31% quarter-over-quarter to $159M.
Based on Industry Ventures's 13F filing for Q1 2022, filed 6 May 2022.